|
AU2013305580A1
|
|
Anxiolytic composition, formulation and method of use
|
|
US2009143436A1
|
|
Anesthetic composition, formulation and method of use
|
|
EP1983827A2
|
|
Use of antifungal compositions to treat upper gastrointestinal conditions
|
|
WO9707750A1
|
|
Administration of ketamine to manage pain and to reduce drug dependency
|
|
CA2213567A1
|
|
Use of ketamine for facilitating detoxification and treatment of smoking addiction, and device therefor
|
|
CA2596947A1
|
|
Nasal and ocular administration of ketamine to manage pain and for detoxification
|
|
MX9706456A
|
|
Nasal and ocular administration of ketamine to manage pain and for detoxification.
|
|
EP0751766A1
|
|
Nasal and ocular administration of ketamine to manage pain and for detoxification
|
